PL1765866T3 - Wydzielanie białek osocza lub surowicy - Google Patents

Wydzielanie białek osocza lub surowicy

Info

Publication number
PL1765866T3
PL1765866T3 PL05746285T PL05746285T PL1765866T3 PL 1765866 T3 PL1765866 T3 PL 1765866T3 PL 05746285 T PL05746285 T PL 05746285T PL 05746285 T PL05746285 T PL 05746285T PL 1765866 T3 PL1765866 T3 PL 1765866T3
Authority
PL
Poland
Prior art keywords
isolation
plasma
serum proteins
serum
proteins
Prior art date
Application number
PL05746285T
Other languages
English (en)
Inventor
Allan Otto Fog Lihme
Original Assignee
Therapure Biopharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Therapure Biopharma Inc filed Critical Therapure Biopharma Inc
Publication of PL1765866T3 publication Critical patent/PL1765866T3/pl

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
    • B01D15/20—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to the conditioning of the sorbent material
    • B01D15/206—Packing or coating
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/42—Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
    • B01D15/424—Elution mode
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL05746285T 2004-06-07 2005-06-07 Wydzielanie białek osocza lub surowicy PL1765866T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DKPA200400891 2004-06-07
DKPA200401062 2004-07-05
PCT/DK2005/000378 WO2005121163A2 (en) 2004-06-07 2005-06-07 Isolation of plasma or serum proteins
EP05746285.5A EP1765866B1 (en) 2004-06-07 2005-06-07 Isolation of plasma or serum proteins

Publications (1)

Publication Number Publication Date
PL1765866T3 true PL1765866T3 (pl) 2014-06-30

Family

ID=34969001

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05746285T PL1765866T3 (pl) 2004-06-07 2005-06-07 Wydzielanie białek osocza lub surowicy

Country Status (10)

Country Link
US (3) US9624260B2 (pl)
EP (3) EP1765866B1 (pl)
CN (2) CN1972961B (pl)
AU (2) AU2005252296B2 (pl)
BR (1) BRPI0511906B1 (pl)
DK (1) DK1765866T3 (pl)
ES (2) ES2606078T3 (pl)
PL (1) PL1765866T3 (pl)
PT (1) PT1765866E (pl)
WO (1) WO2005121163A2 (pl)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1664123B2 (en) 2003-09-22 2011-11-30 Kamada Ltd. Large scale preparation of alpha-1 proteinase inhibitor and use thereof
NZ546942A (en) 2003-11-08 2010-03-26 Prothera Biolog Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use
WO2005121165A1 (en) * 2004-06-07 2005-12-22 Avt Plasma Limited Process for protein isolation
ES2606078T3 (es) 2004-06-07 2017-03-17 Therapure Biopharma Inc. Aislamiento de proteínas del plasma
WO2007063129A2 (en) * 2005-12-02 2007-06-07 Novozymes A/S Insolation of peptides , polypeptides and proteins
US9433922B2 (en) * 2007-08-14 2016-09-06 Emd Millipore Corporation Media for membrane ion exchange chromatography based on polymeric primary amines, sorption device containing that media, and chromatography scheme and purification method using the same
US20120177610A1 (en) 2007-09-19 2012-07-12 Kieu Hoang Manufacturing and Purification Processes of Complex Protein found in Fraction IV to make a separated Apo, Transferrin , and Alpha 1 Anti strepsin (A1AT) or A combined Transferrin / Apo/Human Albumin/A1AT and all new found proteins
BRPI0913949A2 (pt) 2008-05-28 2015-10-20 Pro Thera Biolog Llc preparação e composição de proteínas inibidoras inter-alfa a partir de sangue
US20110065900A1 (en) * 2008-05-30 2011-03-17 Ge Healthcare Bio-Science Ab Separation method utilizing polyallylamine ligands
RU2567811C2 (ru) * 2008-06-24 2015-11-10 Октафарма Аг Способ очистки фактора свертывания крови viii
BRPI0917656A2 (pt) 2008-08-21 2017-07-11 Octapharma Ag Fatores viii e ix humanos produzidos de forma recombinante
US8945895B2 (en) 2009-07-31 2015-02-03 Baxter International Inc. Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof
BR112012024550B1 (pt) 2010-03-30 2020-12-08 Octapharma Ag processo de produção de uma proteína dependente de vitamina k livre de príons em uma sequência de purificação que emprega cromatografia
RU2015149979A (ru) 2010-03-30 2019-01-15 Октафарма Аг Способ очистки белка фактора роста
CA2821711C (en) 2010-12-15 2017-10-10 Baxter International Inc. Eluate collection using conductivity gradient
FR2977893B1 (fr) * 2011-07-11 2015-02-20 Lab Francais Du Fractionnement Procede de preparation d'un concentre d'immunoglobulines polyvalentes
US8802448B2 (en) 2011-07-27 2014-08-12 Pall Corporation Mixed mode ligands
TW201335181A (zh) * 2012-01-31 2013-09-01 Kieu Hoang ５５種新發現的蛋白質之序列及其應用
CN102532307B (zh) * 2012-02-22 2013-06-12 成都蓉生药业有限责任公司 一种制备人免疫球蛋白的方法
GB201206530D0 (en) * 2012-04-13 2012-05-30 Vivacta Ltd An assay label
US20140031527A1 (en) * 2012-07-27 2014-01-30 Csl Limited Method for polishing albumin
US9572872B2 (en) 2012-09-09 2017-02-21 Prothera Biologics, Inc. Treatment of disease using inter-alpha inhibitor proteins
CN102977180B (zh) * 2012-11-06 2016-03-16 中国科学院过程工程研究所 一种综合利用Cohn组分IV的方法
US20140206844A1 (en) 2013-01-18 2014-07-24 Prothera Biologics Methods for isolating blood products from an inter-alpha inhibitor protein-depleted blood product material
CN103130868B (zh) * 2013-03-12 2014-09-17 合肥天麦生物科技发展有限公司 一种蛋白质或多肽的纯化方法
CN104236983A (zh) * 2013-06-14 2014-12-24 中国科学院大连化学物理研究所 溶液样品中含长烷基链的离子液体的去除方法
US9663553B2 (en) * 2014-01-29 2017-05-30 Hemarus Therapeutics Limited Integrated process for the production of therapeutics (human albumin, immunoglobulins, clotting factor VIII and clotting factor IX) from human plasma
CN108463471A (zh) * 2015-09-28 2018-08-28 K·黄 用pH梯度法从动物或人体血浆或从植物中分离蛋白质的方法
CN106085992A (zh) * 2016-06-16 2016-11-09 武汉中原瑞德生物制品有限责任公司 一种提高人凝血酶原复合物中fⅶ收率的方法
US11866743B1 (en) 2017-05-31 2024-01-09 Teledyne Flir Detection, Inc. Pharmaceutical formulations, methods for treating chemical warfare agent exposure, and modified biomolecules
JP7218344B2 (ja) * 2017-07-10 2023-02-06 武田薬品工業株式会社 液体をインキュベートおよびウイルスを不活化するための方法
WO2020160505A1 (en) * 2019-02-01 2020-08-06 Ohio State Innovation Foundation Methods of protein purification
CN110215740B (zh) * 2019-07-15 2021-05-04 大连医科大学 一种两性离子亲水前处理硅胶材料的制备方法
CN110215739A (zh) * 2019-07-15 2019-09-10 大连医科大学 一种离子型亲水前处理硅胶材料的制备方法
CN111603802A (zh) * 2020-05-10 2020-09-01 上海灿实工程设备有限公司 一种用于血液制品的吸附罐
CN112409476B (zh) * 2020-08-13 2022-03-29 中元汇吉生物技术股份有限公司 四种血液来源蛋白的纯化方法
EP4240757A2 (en) 2020-11-09 2023-09-13 Takeda Pharmaceutical Company Limited Purification of fviii from plasma using silicon oxide adsorption
CN112250757A (zh) * 2020-11-13 2021-01-22 广东深蓝生物科技有限公司 一种猪血浆中蛋白质的提取纯化方法
CN112827217A (zh) * 2020-12-29 2021-05-25 苏州良辰生物医药科技有限公司 一种层析柱清洗液及其应用
US20240352065A1 (en) * 2021-09-28 2024-10-24 LIHME PROTEIN SOLUTIONS ApS Improved protein sorption and filtration apparatus
CN116217710A (zh) * 2023-04-23 2023-06-06 华兰生物工程重庆有限公司 一种从血浆中提取分离IgM与凝血因子Ⅶ的方法

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2390074A (en) 1942-02-09 1945-12-04 Research Corp Protein product and process
US2469193A (en) 1942-02-09 1949-05-03 Research Corp Protein fractionation
US4156681A (en) 1974-03-28 1979-05-29 Plasmesco Ag Process for isolating albumin from blood
JPS57168157A (en) 1981-02-12 1982-10-16 Asahi Chem Ind Co Ltd High performance liquid chromatography column and analysis method using the same
US4481189A (en) 1982-04-14 1984-11-06 New York Blood Center Inc. Process for preparing sterilized plasma and plasma derivatives
US4749783A (en) * 1986-07-11 1988-06-07 Miles Laboratories, Inc. Viral inactivation and purification of active proteins
US5258503A (en) * 1987-09-08 1993-11-02 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Autoantibody adsorbent and apparatus for removing autoantibodies using the same
US5055485A (en) * 1988-12-02 1991-10-08 New York Blood Center, Inc. Inactivation of viruses in cell- and protein-containing compositions using aryl diol epoxides
DK165090D0 (da) 1990-07-09 1990-07-09 Kem En Tec As Konglomererede partikler
DK52791D0 (da) 1991-03-22 1991-03-22 Kem En Tec As Adsorptionsmatricer
SE9101149D0 (sv) 1991-04-17 1991-04-17 Pharmacia Lkb Biotech Beads for down stream processing
US5502022A (en) 1994-05-16 1996-03-26 Biosepra, Inc. Chromatography adsorbents utilizing mercapto heterocyclic ligands
CA2157219C (en) 1994-08-31 2010-10-05 Munehiro Noda Process for purifying recombinant human serum albumin
US5837826A (en) 1995-02-27 1998-11-17 Regents Of The University Of Minnesota Protein adsorption by very dense porous zirconium oxide particles in expanded beds
SE9503926D0 (sv) * 1995-11-07 1995-11-07 Pharmacia Biotech Ab Adsorptionsförfarande och separationsmedium
TW491855B (en) * 1996-08-07 2002-06-21 Csl Ltd Purification of immunoglobulins
JP4425994B2 (ja) * 1996-08-30 2010-03-03 ウプフロント クロマトグラフィー アクティーゼルスカブ 免疫グロブリンの単離
IL137649A (en) * 1998-02-18 2004-08-31 Genentech Inc Method of adsorption chromatography
US20020104801A1 (en) 1998-04-06 2002-08-08 Nicolas Voute Small dense microporous solid support materials, their preparation,and use for purification of large macromolecules and bioparticles
DE19823814A1 (de) 1998-05-27 1999-12-02 Octapharma Ag Ziegelbruecke Verfahren zur Trennung und/oder Isolierung von Plasmaproteinen mit annularer Chromatographie
EP1087828B1 (en) * 1998-06-18 2008-09-17 Upfront Chromatography A/S Expanded bed adsorption system
WO2000025883A1 (en) 1998-10-31 2000-05-11 Amersham Pharmacia Biotech Ab A new system and its units
WO2000057982A1 (en) 1999-03-26 2000-10-05 Upfront Chromatography A/S Fluidised bed purification of bio-macromolecules such as plasmid dna, chromosomal dna, rna, viral dna, bacteria and viruses
AU5823801A (en) 2000-05-12 2001-11-20 Upfront Chromatography As A bed adsorption system
SE0100714D0 (sv) 2000-07-13 2001-02-28 Ap Biotech Ab Reaction vessel and method for distributing fluid in such a vessel
EP1345666A1 (en) 2000-12-29 2003-09-24 Upfront Chromatography A/S Extracorporeal capturing of specific bio-macromolecular entities from extracellular body fluids
EP2272378B1 (en) 2001-06-01 2014-08-06 Upfront Chromatography A/S Fractionation of protein containing mixtures
CN1207064C (zh) * 2002-03-29 2005-06-22 华兰生物工程股份有限公司 一种冻干人纤维蛋白胶的生产工艺
JP2005532130A (ja) 2002-07-11 2005-10-27 アップフロント・クロマトグラフィ・アクティーゼルスカブ 敗血症治療のための体外流動膨張床方法
NZ542956A (en) 2003-03-21 2007-11-30 Upfront Chromatography As Method for high throughput volumes in the fractionation of bio-molecules by chromatographic systems
ES2606078T3 (es) 2004-06-07 2017-03-17 Therapure Biopharma Inc. Aislamiento de proteínas del plasma
ES2647925T3 (es) * 2011-05-12 2017-12-27 Csl Behring Gmbh Métodos para reducir los eventos adversos causados por preparados farmacéuticos que comprenden proteínas derivadas del plasma

Also Published As

Publication number Publication date
US9428545B2 (en) 2016-08-30
BRPI0511906A (pt) 2008-01-15
CN1972961B (zh) 2012-12-26
ES2606078T3 (es) 2017-03-17
US20170282095A1 (en) 2017-10-05
AU2009238344A1 (en) 2009-12-10
DK1765866T3 (en) 2014-03-24
US9624260B2 (en) 2017-04-18
AU2005252296B2 (en) 2009-08-20
CN102924565A (zh) 2013-02-13
CN1972961A (zh) 2007-05-30
ES2454566T3 (es) 2014-04-10
WO2005121163A3 (en) 2006-03-23
EP2277912A3 (en) 2011-05-04
WO2005121163A2 (en) 2005-12-22
BRPI0511906B1 (pt) 2021-11-30
PT1765866E (pt) 2014-04-14
EP1765866B1 (en) 2014-01-08
EP1765866A2 (en) 2007-03-28
US20070299251A1 (en) 2007-12-27
US20160009757A1 (en) 2016-01-14
EP2277912A2 (en) 2011-01-26
AU2009238344B2 (en) 2012-02-16
EP3127916A1 (en) 2017-02-08
AU2005252296A1 (en) 2005-12-22
EP2277912B1 (en) 2016-09-28

Similar Documents

Publication Publication Date Title
PL1765866T3 (pl) Wydzielanie białek osocza lub surowicy
EP1739093B8 (fr) Séparation de protéines plasmatiques
DE602005009729D1 (de) System zur zubereitung von getränken
WO2007070538A9 (en) Anti-mn antibodies and methods of using same
PL1735440T3 (pl) Reagenty i sposoby izolacji oczyszczonego RNA
HK1103944A1 (en) Novel canola protein isolate
IL182626A0 (en) Methods for refolding of recombinant antibodies
EP1773881A4 (en) Inhibition of macrophage-stimulating protein receptor (RON)
EP1869192A4 (en) FRAME MIXTURE OF ANTIBODIES
EP1758968A4 (en) IMPROVED SEPARATION OF COMPLEX MIXTURES
GB0426160D0 (en) Production of proteins
EP1914315A4 (en) METHOD FOR DETERMINING A GLYCOSYLATED PROTEIN AND DETERMINING KIT
GB0426161D0 (en) Protein isolation and purification
IL179901A0 (en) Process for protein isolation
IL183106A0 (en) Production of proteins
GB0423974D0 (en) Proteins
ZA200700167B (en) Process for protein isolation
EP1760149A4 (en) PROCESS FOR CONSTRUCTING MODIFIED PROTEIN
EP1751174A4 (en) PROTEIN INHIBITORS REGIII, THERAPEUTIC AGENTS AGAINST ASTHMA
EP1739089A4 (en) PROCESS FOR DISINTER SEPARATION
AU2004906748A0 (en) Improved Detection of Proteins
AU2004903045A0 (en) Process for Protein Isolation
AU2004902112A0 (en) Identification of placental proteins
AU2004900731A0 (en) Methods of sequence determination
AU2004906688A0 (en) Inhibitors of biotin protein ligase